LIFE: Lifecare newsletter April 2022

Bergen, Norway 4 April 2022 

Demonstration of nano-scale dispensing of biochemical solutions on the Sencell
chip and an article in the Norwegian Technical Weekly. Upcoming events and an
operational update.  

Read more in the Lifecare April newsletter: 
https://lifecare.no/news/information-from-lifecare-april-2022/

This is Lifecare 
Lifecare is a Bergen-based technology company developing a miniaturized
implantable long-term sensor for correct and continuous monitoring of blood
sugar in people with diabetes. The Company's patented technology also has the
potential for use in various biomarkers. Lifecare AS is listed on Euronext
Growth (LIFE). 

Further information Joacim Holter, CEO, Lifecare AS, joacim.holter@lifecare.no,
+47 40 05 90 40 

This stock exchange announcement was published by Kine Hereid, Investor
Relations at Lifecare AS, on 04.04.22 at 09:00 CET.